Immuneering Corporation is a biopharmaceutical company. The provided filing excerpt is an auditor consent from RSM US LLP, not a business description, and contains insufficient information to describe the company's specific products, services, or operations in detail. The document references consolidated financial statements for the year ended December 31, 2025, filed as an Annual Report on Form 10-K.
Q2 FY2026 — expected 2026-09-17
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-06 | 2025-12-31 | 0001790340-26-000042 | EDGAR | 100K words |
| 2025-03-20 | 2024-12-31 | 0001790340-25-000042 | EDGAR | 94K words |
| 2024-03-01 | 2023-12-31 | 0001790340-24-000024 | EDGAR | 93K words |
| 2023-03-06 | 2022-12-31 | 0001558370-23-002905 | EDGAR | 93K words |
| 2022-03-10 | 2021-12-31 | 0001558370-22-003208 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-05 | 2026-06-30 | 0001790340-26-000091 | EDGAR | 70K words |
| 2025-11-12 | 2025-09-30 | 0001790340-25-000135 | EDGAR | 70K words |
| 2025-08-13 | 2025-06-30 | 0001790340-25-000104 | EDGAR | 65K words |
| 2025-05-05 | 2025-03-31 | 0001790340-25-000061 | EDGAR | 63K words |
| 2024-11-13 | 2024-09-30 | 0001790340-24-000080 | EDGAR | 65K words |
| 2024-08-06 | 2024-06-30 | 0001790340-24-000066 | EDGAR | 63K words |
| 2024-05-07 | 2024-03-31 | 0001790340-24-000056 | EDGAR | 61K words |
| 2023-11-09 | 2023-09-30 | 0001790340-23-000056 | EDGAR | 65K words |
| 2023-08-03 | 2023-06-30 | 0001790340-23-000048 | EDGAR | 65K words |
| 2023-05-04 | 2023-03-31 | 0001790340-23-000023 | EDGAR | 63K words |
| 2022-11-10 | 2022-09-30 | 0001558370-22-017304 | EDGAR | 68K words |
| 2022-08-10 | 2022-06-30 | 0001558370-22-013063 | EDGAR | 67K words |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-08-05 | 0001790340-26-000088 | EDGAR | 3K words |
| 2026-03-06 | 0001790340-26-000040 | EDGAR | 3K words |
| 2026-01-07 | 0001790340-26-000006 | EDGAR | 1K words |
| 2025-11-12 | 0001790340-25-000133 | EDGAR | 3K words |
| 2025-09-25 | 0001104659-25-093436 | EDGAR | 18K words |
| 2025-09-24 | 0001104659-25-092957 | EDGAR | 1K words |
| 2025-08-25 | 0001104659-25-081995 | EDGAR | 1K words |
| 2025-08-13 | 0001790340-25-000102 | EDGAR | 3K words |
| 2025-06-17 | 0001790340-25-000077 | EDGAR | 1K words |
| 2025-06-16 | 0001790340-25-000063 | EDGAR | 1K words |
79 total filings indexed. 52 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001790340 |
| Ticker | IMRX |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Headquarters | Boston, Massachusetts |
| Website | https://www.immuneering.com |
| Listed | 2021-07-30 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/IMRX (~200 tokens, structured JSON with cryptographic provenance)